Seeplex® H. pylori-ClaR ACE Detection simultaneously detects and identifies two types of point mutations (A2143G and A2142G) causing clarithromycin-resistance in Helicobacter pylori from direct examination of gastric biopsy tissue without going through bacterial culture. Based on DPO™ technology, this assays performs on PCR instruments and applicable for Auto-capillary Electrophoresis instruments.
Features
-
Multiplex PCR
Simultaneous identification of H. pylori and two point mutations (A2143G & A2142G), which cause clarithromycin resistance without culture
-
Reduction Contamination risk
A single round PCR process and 8-MOP reduces the carryover contamination risk
-
Prediction of antibiotic resistance
Detection and identification of mutations associated antibiotic resistance for appropriate infection control
-
Powerful performance with unique technology
Multiplex PCR with high sensitivity and specificity by utilization of DPO™ technologies
-
Analytes
Seeplex®
H. pylori-ClaR ACE Detection
- A2142G
- A2143G
- Helicobacter pylori (H. pylori)
- Internal Control (IC)
-
Specimen
- Gastric biopsy
-
Ordering Information
ProductCat No. / SizeSeeplex® H. pylori-ClaR ACE Detection
Result
| ID | Result |
|---|---|
| 1 | H. pylori |
| 2 | H. pylori, A2143G |
| 3 | H. pylori |
| 4 | H. pylori, A2143G |
| 5 | H. pylori, A2142G |
| 6 | H. pylori, A2143G |
| 7 | H. pylori, A2142G |
| 8 | H. pylori |
1~8: Clinical samples
